Shielding Patients Means Low Dose for Operators, Too
Lead shielding patients helps protect operators from radiation exposure during cardiac catheterization, but shielding is less effective for the radial approach than for the femoral approach.
Pelvic lead shielding of patients reduces radiation exposure to operators during radial and femoral cardiac catherization, but radial access is still associated with a higher operator radiation dose, show results of a study published in April’s issue of JACC: Cardiovascular Interventions.
Researchers from Breman, Germany, assigned 210 patients to undergo either radial or femoral access coronary angiography with and without pelvic lead shielding of the patient. Operator exposure was measured by a radiation dosimeter attached to the outside breast pocket of the lead apron.
Operator dose decreased from 20.9 mSv to 9.0 mSv during the radial access, with pelvic lead shielding, and decreased from 15.3 mSv to 10.4 mSv during the femoral access.
While these findings show a decrease in exposure, more research is needed to further minimize operator exposure to radiation, concluded the authors of the study.
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Where Things Stand with the Radiologist Shortage
June 18th 2025A new report conveys the cumulative impact of ongoing challenges with radiologist residency positions, reimbursement, post-COVID-19 attrition rates and the aging of the population upon the persistent shortage of radiologists in the United States.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
